A microbial signature for Crohn's disease-Reference-Cited by-同舟云学术

A microbial signature for Crohn's disease

Published:2017-02-07 Issue:5 Volume:66 Page:813-822
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Pascal Victoria,Pozuelo Marta,Borruel Natalia,Casellas Francesc,Campos David,Santiago Alba,Martinez Xavier,Varela Encarna,Sarrabayrouse Guillaume,Machiels Kathleen,Vermeire Severine,Sokol Harry,Guarner Francisco,Manichanh Chaysavanh

Funder

Instituto de Salud Carlos III

Publisher

BMJ

Subject

Gastroenterology

Reference34 articles.

1. The global burden of IBD: from 2015 to 2025;Kaplan;Nat Rev Gastroenterol Hepatol,2015

2. The treatment-naive microbiome in new-onset Crohn's disease;Gevers;Cell Host Microbe,2014

3. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach;Manichanh;Gut,2006

4. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease;Ott;Gut,2004

5. Fungal microbiota dysbiosis in IBD;Sokol;Gut,2016

Cited by 639 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of the gut microbiota and its application in inflammatory bowel disease;Biomedicine & Pharmacotherapy;2024-10

2. Interactions between soluble dietary fibers from three edible fungi and gut microbiota;International Journal of Biological Macromolecules;2024-10

3. Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease;Journal of Controlled Release;2024-09

4. Exploring the interactions of JAK inhibitor and S1P receptor modulator drugs with the human gut microbiome: Implications for colonic drug delivery and inflammatory bowel disease;European Journal of Pharmaceutical Sciences;2024-09

5. Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence;United European Gastroenterology Journal;2024-08-31